Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Bimatoprost 0.01% vs 0.03% in Glaucoma
NCT01298700Phase 4Completed
- Sponsor
- Allergan
- Start
- May 2011
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 4 trial of bimatoprost in Glaucoma, ocular hypertension, sponsored by Allergan. Started May 2011; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01298700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298700.